Ppt on peptic ulcer drugs kdt based
Peptic Ulcer Drugs KDT
Presentation Β· PPTX
| Slide | Content |
|---|---|
| 1 | Title Slide β Drugs for Peptic Ulcer Disease (KDT-based) |
| 2 | Pathophysiology β Aggressive vs Defensive factors |
| 3 | KDT Classification β All 6 groups in color-coded cards |
| 4 | Antacids β Systemic vs Non-systemic, 4 drugs compared |
| 5 | Hβ Blockers β Mechanism + all 4 drugs (dose, features, SE) |
| 6 | Proton Pump Inhibitors β MOA + all 6 PPIs with doses |
| 7 | PPI Adverse Effects & Clinical Uses β Long-term risks |
| 8 | Anti-H. pylori Regimens β Triple, Quadruple, Concomitant |
| 9 | Mucosal Protective Agents β Sucralfate, Misoprostol, Bismuth, Carbenoxolone |
| 10 | Anticholinergics & Miscellaneous β Pirenzepine, Vonoprazan, Rebamipide |
| 11 | Comparison Table β Antacids vs Hβ Blockers vs PPIs |
| 12 | NSAID-Induced Ulcer & Special Situations β Pregnancy, ZES, ICU |
| 13 | Drug Interactions & High-Yield Points β Exam essentials |
| 14 | Treatment Algorithm Flowchart β H. pylori +ve vs -ve |
| 15 | Thank You / References |
Try again